LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00556088
Recruitment Status : Completed
First Posted : November 9, 2007
Last Update Posted : December 30, 2010
Information provided by:
SCRI Development Innovations, LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2010
  Study Completion Date : July 2010